NEW YORK — Two Sigma Ventures today announced the closing of two venture funds aiming to propel the next era of tech innovation forward.
Totaling $400M across both funds, Two Sigma Ventures IV (TSV IV) will invest in early-stage startups, and Two Sigma Ventures Opportunity Fund II (TSV Opps II) will invest in growth-stage companies.
Approximately 85% of the new capital comes from external investors, primarily institutions such as college endowments, non-profit foundations, pension funds, and hospital systems, with the remainder of the capital coming from Two Sigma’s partners and senior employees.
“We’re fortunate to have the consistent backing of many preeminent institutions who have supported us over the years on our mission to build a world-class venture capital firm”
Two Sigma Ventures invests across many industries including enterprise SaaS, fintech, techbio, consumer tech, crypto and defi, and more. The business looks for founders and companies working on novel discoveries leveraging data science and computing advances across these high-impact verticals and markets. The new capital will allow TSV to invest in breakthrough companies fundamentally changing the ways society and technology interact, transforming traditional industries, and helping to move humanity forward.
“We started Two Sigma Ventures a decade ago with the belief that, as the world becomes more information-rich, most new companies that change the world will do so using some combination of data science and advanced computing,” said Colin Beirne, partner at Two Sigma Ventures.
“In the last 10 years we’ve backed over 100 companies aligned with that thesis, and are proud of the successes our founders have experienced. This new infusion of capital is the beginning of our next chapter as a business and will allow us to fund the next generation of entrepreneurs with world-changing ideas.”
Founded in 2012 as the venture arm of the $60B+ financial sciences company Two Sigma, Two Sigma Ventures innovates upon the traditional VC model by supporting its startups with not only strategic counsel, but also hands-on expertise in software engineering, data science, quantitative modeling, machine learning, and more. Two Sigma Ventures invests in founders with a long-term vision, and aims to be an enduring partner to every company in its portfolio.
“The team at Two Sigma Ventures has been instrumental in propelling us forward, especially during these times of economic uncertainty,” said Job van der Voort, co-founder and CEO of Remote.
“Two Sigma Ventures was an early supporter of ours who understood how data can be harnessed for insights and intelligence,” said Will Ahmed, co-founder and CEO of WHOOP. “We’ve developed novel health monitoring techniques and their expertise in data science and engineering have been tremendously helpful to us through the years.”
“We’re fortunate to have the consistent backing of many preeminent institutions who have supported us over the years on our mission to build a world-class venture capital firm,” said Villi Iltchev, partner at Two Sigma Ventures.
If you lead an early or growth stage startup and are in need of a strategic venture partner, reach out to the team at Two Sigma Ventures today.
About Two Sigma Ventures
Two Sigma Ventures (TSV) invests in entrepreneurs doing big things with data. TSV was founded in 2012 by Two Sigma, the $60B+ financial sciences company, and invests in early and growth stage companies across many industries including enterprise SaaS, fintech, techbio, consumer tech, crypto and defi, and more. Headquartered in New York, TSV has provided capital, strategic counsel, and industry expertise to innovative companies, such as GitLab, Recursion Pharmaceuticals, Remote, WHOOP, Carbon Health, insitro, Socure, Wealthsimple, Timescale, and more.